This reluctance may be informed by clinical practice guidelines for dementia that do not advocate routine APOE testing (Japanese Society of Neurology n.d.) and by another set of guidelines that recommend APOE testing after thorough consideration of its validity and utility (The Japanese Association of Medical Sciences n.d.; Ethical guidelines for medical and biological research involving human subjects n.d.). This evidence concerns the gene APOE and dementia.